Measuring the C-reactive protein (CRP) level in patients admitted with ST-segment elevation acute myocardial infarction (MI) may be useful in predicting whether thrombolytic therapy will be successful, according to a recent report.
Furthermore, such levels appear to correlate with short- and long-term cardiac mortality, Dr. Michael Zairis and colleagues, from Tzanio Hospital in Piraeus, Greece, note in the November issue of the American Heart Journal.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!